Orchard Therapeutics Reached An Agreement With The Beneluxa Initiative On Pharmaceutical Policy (Beneluxa) Enabling Reimbursed Access To Libmeldy= (atidarsagene autotemcel) Approved For The Treatment Of Early-onset Metachromatic Leukodystrophy (MLD)